title: Revision of Import and Export Requirements for Controlled Substances, Listed Chemicals, and Tableting and Encapsulating Machines, Including Changes To Implement the International Trade Data System (ITDS); Revision of Reporting Requirements for Domestic Transactions in Listed Chemicals and Tableting and Encapsulating Machines; and Technical Amendments. Final rule.
abstract: The Drug Enforcement Administration is updating its regulations for the import and export of tableting and encapsulating machines, controlled substances, and listed chemicals, and its regulations relating to reports required for domestic transactions in listed chemicals, gamma-hydroxybutyric acid, and tableting and encapsulating machines. In accordance with Executive Order 13563, the Drug Enforcement Administration has reviewed its import and export regulations and reporting requirements for domestic transactions in listed chemicals (and gamma-hydroxybutyric acid) and tableting and encapsulating machines, and evaluated them for clarity, consistency, continued accuracy, and effectiveness. The amendments clarify certain policies and reflect current procedures and technological advancements. The amendments also allow for the implementation, as applicable to tableting and encapsulating machines, controlled substances, and listed chemicals, of the President's Executive Order 13659 on streamlining the export/import process and requiring the government-wide utilization of the International Trade Data System (ITDS). This rule additionally contains amendments that implement recent changes to the Controlled 
  Substances Import and Export Act (CSIEA) for reexportation of controlled substances among members of the European Economic Area made by the Improving Regulatory Transparency for New Medical Therapies Act. The rule also includes additional substantive and technical and stylistic amendments.
mesh_terms: D002214:Capsules; D003132:Commerce / Q000331:legislation & jurisprudence*; D061891:Controlled Substances; D004339:Drug Compounding / Q000295:instrumentation; D004348:Drug Labeling / Q000331:legislation & jurisprudence; D004349:Drug Packaging / Q000331:legislation & jurisprudence; D004335:Drug and Narcotic Control / Q000331:legislation & jurisprudence*; D001330:Electronic Data Processing / Q000331:legislation & jurisprudence; D004809:Ephedrine; D006801:Humans; D006885:Hydroxybutyrates; D007256:Information Systems / Q000331:legislation & jurisprudence; D010665:Phenylpropanolamine; D010865:Pilot Projects; D064226:Prescription Drug Diversion / Q000331:legislation & jurisprudence* / Q000517:prevention & control; D054199:Pseudoephedrine; D013607:Tablets; D014481:United States
chemical_list: D002214:Capsules; D061891:Controlled Substances; D006885:Hydroxybutyrates; D013607:Tablets; D010665:Phenylpropanolamine; D054199:Pseudoephedrine; D004809:Ephedrine